Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012–2016 | Zendy

Lindley A. Barbee | Zendy; Olusegun O. Soge | Zendy; David A. Katz | Zendy; Julia C. Dombrowski | Zendy; King K. Holmes | Zendy; Matthew R. Golden | Zendy

Open Access

Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012–2016

Author(s) -

Lindley A. Barbee,

Olusegun O. Soge,

David A. Katz,

Julia C. Dombrowski,

King K. Holmes,

Matthew R. Golden

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix898

Subject(s) - gonorrhea , medicine , neisseria gonorrhoeae , azithromycin , ceftriaxone , men who have sex with men , sexually transmitted disease , antibiotics , microbiology and biotechnology , family medicine , syphilis , biology , human immunodeficiency virus (hiv)

Antimicrobial-resistant Neisseria gonorrhoeae is a major public health threat. The Centers for Disease Control and Prevention (CDC) recommends ceftriaxone 250 mg plus azithromycin (AZM) 1 g for gonorrhea treatment. Resistance to AZM could affect gonorrhea control efforts.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research